2018 Announcements
CLINUVEL sustains profitability first-half of year
28 February 2018
CLINUVEL PHARMACEUTICALS LTD today announced financial results for the half year ended 31 December 2017, reporting net profit after tax of A$1.41m, and total revenues of A$7.19m:
- total revenues: A$7.19 million
- 3% increase in total revenues PRP
- commercial sales revenues: A$5.33 million
- cash increase from 30 June 2017: A$4.19 million
- net profit after tax: A$1.41 million (44% decrease PRP)
- growth in number of expert treatment centres prescribing SCENESSE®